Pain reliever use in pregnancy shows no link to child neurodevelopmental disorders, study finds

Extensive study explores acetaminophen use during pregnancy, analyzing its potential association with intellectual disability, ADHD, and autism in children, and ultimately finding no link when considering sibling analyses to control for unmeasured confounding factors.

Illumina and Guardant agree to dismiss litigation, share specimen samples after year-long legal battle

After throwing accusations of retaliation and stealing trade secrets in court, Illumina and diagnostics company Guardant Health have come to a three-year agreement that includes

August 3, 2023

ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation

ePrep is delighted to announce a new partnership with Agilent – a global leader in technology platforms for analytical laboratories – for the distribution of

June 5, 2024

Once-Weekly Pediatric Growth Hormone Snags FDA Approval

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for

July 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.